Biohaven Ltd (NYSE:BHVN) Stock News, Headlines & Updates
Biohaven Ltd Stock News from GuruFocus
- 1
May 29, 2024
Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day
PRNewswire • 7:00am
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors
PRNewswire • 7:00am
May 15, 2024
Director Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN)
GuruFocus Research • 9:00am
May 09, 2024
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
PRNewswire • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news